Suzhou Teligene Ltd.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| TL938 and Trastuzumab for Patients With HER2-positive Metastatic Colorectal Cancer (NCT06589830) | Suzhou Teligene Ltd. | 2025-05-13 |
Track Suzhou Teligene Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.